Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA for Overactive Bladder: Double-blind Randomized Placebo-controlled Trial
jRCTs061220050Completed
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in overactive bladder (OAB) comparing 5-aminolevulinic acid with Placebo (2 arms). Started Aug 2022; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCTs061220050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220050.